Peptides DB
Research-centric peptide and protocol reference hub
Study 24 of 29SS-31 literaturebiorxiv-preprint · Meta-analysis2026

Parent-mediated interventions versus usual care in children with autism: A systematic review with meta-analysis and Trial Sequential Analysis

This meta-analysis found no significant benefits of parent-mediated interventions on autism characteristics or related outcomes, indicating that further research is needed to evaluate their effectiveness.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the ss-31 corpus
2
Preclinical
20
Observational
0
Open-label
3
Randomised
4
Reviews · this one

Summary and findings

This systematic review and meta-analysis evaluated the effects of parent-mediated interventions (PMIs) versus usual care in children with autism. A total of 32 trials involving 1,625 participants were included. The analysis found no significant benefits of PMIs on autism characteristics or other secondary outcomes.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
MD = −0.88; 95% confidence interval −2.92 to 1.15; p = 0.05, 4 trials, N = 353, low certainty.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

<h4>Objectives</h4> To evaluate the positive and adverse effects of parent-mediated interventions (PMIs) versus care as usual for children with autism. <h4>Setting</h4> Systematic review and meta-analysis and Trial Sequential Analyses (TSA), following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. <h4>Methods</h4> We searched for randomised clinical trials of PMIs for children with autism in the databases CENTRAL, EMBASE, LILACS, PsycINFO, MEDLINE, and SCI-EXPANDED (up to 13 August, 2025), complemented with manual searches. 12,359 articles were screened. Data were synthesised using meta-analyses and Trial Sequential Analyses (TSA), and risks of bias and certainty of the evidence were evaluated. <h4>Primary and secondary outcome measures</h4> The primary outcome was autism characteristics. Secondary outcomes were adverse effects, child adaptive functioning, child language, child and parent quality of life, and parental stress. Ten exploratory outcomes were included. <h4>Results</h4> 32 trials (N=1,625) comparing PMIs to usual care, waiting list, or no intervention were included. All trials had a high risk of bias. The multiplicity-adjusted threshold for statistical significance was p = 0.013 due to the number of outcomes. Meta-analyses and TSAs showed it could be rejected that PMIs reduced autism characteristics (MD = −0.88; 95% confidence interval −2.92 to 1.15; p = 0.05, 4 trials, N =353, low certainty), child adaptive functioning (7 trials, N =408), child language (4 trials, N =308), or parental stress (7 trials, N =385). Due to insufficient data, the remaining secondary meta-analyses could not be conducted. Meta-analyses of exploratory outcomes showed beneficial effects concerning child behaviour problems and parent sensitivity/synchronicity. <h4>Conclusions</h4> This meta-analysis found no benefits of PMIs on child autism characteristics, child adaptive functioning, child language, or parental stress. Benefits were found in reduction of child behaviour problems and improved parent sensitivity/synchronicity. The evidence remains uncertain, and more trials including outcomes of adverse effects and quality of life are needed. <h4>Trial registration</h4> CRD42022385188 PROSPERO

Background

The study aims to evaluate the effectiveness of parent-mediated interventions compared to usual care in children with autism. This is important as autism interventions often involve family participation, and understanding their impact can guide treatment strategies. The study uses systematic review and meta-analysis methods, which are valuable for synthesizing existing evidence.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

  • Not reported in abstract.

Elsewhere in the SS-31 corpus

DStatistical analysis plan for the ‘Pharyngeal electrical stimulation for acute stroke dysphagia trial’ (PhEAST) (ISRCTN98886991)biorxiv-preprint · 2026 · Not reported in abstract.reviewAUse of nicotine replacement therapy to reduce children’s exposure to second-hand smoke in the home: Findings of a pilot randomised controlled trial conducted in Scotlandbiorxiv-preprint · 2026 · Median PM 2.5 concentrations reduced in the intervention group by -36μg/m 3.HumanACardiovascular and autonomic responses to transcutaneous spinal cord stimulation combined with activity-based therapy after chronic spinal cord injury: An exploratory study from the MACHINE trialbiorxiv-preprint · 2026 · Not reported in abstract.HumanBOptimising the prevention, detection and management of diabetes distress in adults with type 1 diabetes: Feasibility study protocol (D-stress feasibility study)biorxiv-preprint · 2026 · Not reported in abstract.HumanBEpidemiology of frailty, multimorbidity, and disability: a cross-sectional study of mid-aged and older adults in The Gambia, Zimbabwe and South Africabiorxiv-preprint · 2026 · Overall mean HRQoL utility score was 0.829 ± 0.107.HumanBClassical driver mutations are not associated with metachronous lesion risk in patients undergoing post-polypectomy surveillance following removal of conventional adenomas in a bowel screening settingbiorxiv-preprint · 2026 · Mutation frequency in index adenomas was not associated with metachronous lesions (p=0.901).Human